Tamar Nijsten

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Impact of melanoma on patients' lives among 562 survivors: a Dutch population-based study
    Cynthia Holterhues
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    Arch Dermatol 147:177-85. 2011
  2. ncbi A costly revolution for a subgroup of patients with metastatic melanoma
    A C J van Akkooi
    Department of Surgical Oncology, Erasmus University Medical Centre Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands Department of Dermatology, Erasmus University Medical Centre, Room GK 016, Burgemeester Jacobsplein 51, 3000 CA Rotterdam, The Netherlands E mail
    Br J Dermatol 168:467-70. 2013
  3. ncbi Dermatology life quality index: time to move forward
    Tamar Nijsten
    Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands
    J Invest Dermatol 132:11-3. 2012
  4. ncbi How epidemiology has contributed to a better understanding of skin disease
    Tamar Nijsten
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    J Invest Dermatol 132:994-1002. 2012
  5. ncbi Dermatologists' views and opinions about photo(chemo)therapy and conventional systemic psoriasis therapies: results from a Belgian survey
    Tamar Nijsten
    Department of Dermatology, University Hospital Antwerp, Edegem, Belgium
    Dermatology 213:123-33. 2006
  6. ncbi Complexity of the association between psoriasis and comorbidities
    Tamar Nijsten
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    J Invest Dermatol 129:1601-3. 2009
  7. ncbi Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients
    Tamar Nijsten
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    J Invest Dermatol 127:2315-22. 2007
  8. ncbi Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials
    Arjen Joosse
    Department of Public Health, Erasmus University Medical Center, PO Box 2040 3000 CA, Rotterdam, The Netherlands
    J Clin Oncol 30:2240-7. 2012
  9. ncbi Gender differences in melanoma survival: female patients have a decreased risk of metastasis
    Arjen Joosse
    Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands
    J Invest Dermatol 131:719-26. 2011
  10. ncbi Risk factors for single and multiple basal cell carcinomas
    Ville Kiiski
    Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
    Arch Dermatol 146:848-55. 2010

Collaborators

Detail Information

Publications47

  1. ncbi Impact of melanoma on patients' lives among 562 survivors: a Dutch population-based study
    Cynthia Holterhues
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    Arch Dermatol 147:177-85. 2011
    ..To assess the impact of melanoma on the health-related quality of life of patients from the general population up to 10 years after diagnosis and its determinants...
  2. ncbi A costly revolution for a subgroup of patients with metastatic melanoma
    A C J van Akkooi
    Department of Surgical Oncology, Erasmus University Medical Centre Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands Department of Dermatology, Erasmus University Medical Centre, Room GK 016, Burgemeester Jacobsplein 51, 3000 CA Rotterdam, The Netherlands E mail
    Br J Dermatol 168:467-70. 2013
    ..Grade 3-4 adverse effects were uncommon in both groups. Interpretation  Dabrafenib significantly improved PFS compared with dacarbazine...
  3. ncbi Dermatology life quality index: time to move forward
    Tamar Nijsten
    Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands
    J Invest Dermatol 132:11-3. 2012
    ..Therefore, it is time to move forward and use valuable alternatives because the DLQI's scientific limitations outweigh the practicalities of its use...
  4. ncbi How epidemiology has contributed to a better understanding of skin disease
    Tamar Nijsten
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    J Invest Dermatol 132:994-1002. 2012
    ....
  5. ncbi Dermatologists' views and opinions about photo(chemo)therapy and conventional systemic psoriasis therapies: results from a Belgian survey
    Tamar Nijsten
    Department of Dermatology, University Hospital Antwerp, Edegem, Belgium
    Dermatology 213:123-33. 2006
    ..Experts' opinions about old and new psoriasis therapies are well documented...
  6. ncbi Complexity of the association between psoriasis and comorbidities
    Tamar Nijsten
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    J Invest Dermatol 129:1601-3. 2009
    ....
  7. ncbi Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients
    Tamar Nijsten
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    J Invest Dermatol 127:2315-22. 2007
    ..Therefore, these instruments should not be used in their current form in international studies...
  8. ncbi Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials
    Arjen Joosse
    Department of Public Health, Erasmus University Medical Center, PO Box 2040 3000 CA, Rotterdam, The Netherlands
    J Clin Oncol 30:2240-7. 2012
    ....
  9. ncbi Gender differences in melanoma survival: female patients have a decreased risk of metastasis
    Arjen Joosse
    Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands
    J Invest Dermatol 131:719-26. 2011
    ..Localized melanomas in women had a lower propensity to metastasize, resulting in a better survival when compared with men, even after first disease progression. These results suggest differences in tumor-host interaction across gender...
  10. ncbi Risk factors for single and multiple basal cell carcinomas
    Ville Kiiski
    Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
    Arch Dermatol 146:848-55. 2010
    ..To investigate the incidence of single and multiple basal cell carcinoma (BCC) lesions and associated risk factors...
  11. ncbi The reduced Impact of Psoriasis Questionnaire has good psychometric properties in Italian patients
    Tamar Nijsten
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    Dermatology 215:348-51. 2007
    ..A recent refinement study suggested that a Rasch reduced version of the Impact of Psoriasis Questionnaire (IPSO) of 11 items most adequately assessed the psychosocial impact of US psoriasis patients...
  12. ncbi Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands
    Sophie C Flohil
    Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Acta Derm Venereol 91:24-30. 2011
    ..Predictions of future trends showed no signs of a plateau in the number of cases. These estimates should urge Dutch policymakers to provide solutions for the growing group of patients with BCC...
  13. ncbi Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort
    Marlies Wakkee
    Department of Dermatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    J Invest Dermatol 130:962-7. 2010
    ..This study, therefore, suggests that psoriasis is not a clinically relevant risk factor for IHD hospitalizations on the population level...
  14. ncbi Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study
    Marlies Wakkee
    Department of Dermatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Acta Derm Venereol 89:476-83. 2009
    ..Psoriasis patients used more cardiovascular-related drugs, but surveillance bias appears to affect this association considerably...
  15. ncbi Categorization of Skindex-29 scores using mixture analysis
    Tamar Nijsten
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    Dermatology 218:151-4. 2009
    ..Although the Skindex-29 is among the most commonly used health-related quality of life instruments in dermatology, the interpretation of obtained scores is not well documented...
  16. ncbi Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005
    Cynthia Holterhues
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    J Invest Dermatol 130:1807-12. 2010
    ..The incidence of UV-related skin tumors increased significantly and more steeply than did those of other skin malignancies...
  17. ncbi Proof-of-principle study of steam ablation as novel thermal therapy for saphenous varicose veins
    Renate R van den Bos
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    J Vasc Surg 53:181-6. 2011
    ..The newest method of thermal ablation is pulsated steam, which works by heating the vein with steam at 120°C. This study assessed the effectiveness of steam ablation of varicose veins in sheep and in humans...
  18. ncbi Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort
    Marlies Wakkee
    Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands
    J Am Acad Dermatol 65:1135-44. 2011
    ..Immunologic alterations caused by psoriasis and/or its therapies may affect the risk of serious infections...
  19. ncbi [Basal cell carcinoma: often more than one]
    Sophie C Flohil
    Erasmus MC Universitair Medisch Centrum, Rotterdam, afd Dermatologie, The Netherlands
    Ned Tijdschr Geneeskd 155:A4110. 2011
    ..To calculate the cumulative risks and incidence rates for the development of multiple (two or more) basal cell carcinomas (BCC)...
  20. ncbi A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: results of a Belgian cross sectional study (BELPSO)
    Julien Lambert
    Department of Dermatology, University Hospital Antwerp, Edegem, Belgium
    Eur J Dermatol 22:231-7. 2012
    ..Although several large observational studies have reported on psoriasis characteristics, very few have included severity assessments by dermatologists and validated health related quality of life measures...
  21. ncbi Critical review of generic and dermatology-specific health-related quality of life instruments
    Hilde Both
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    J Invest Dermatol 127:2726-39. 2007
    ..Promising new instruments for future research are the WHOQOL and the Skindex-17...
  22. ncbi The psychometric properties of the psoriasis disability index in United States patients
    Tamar Nijsten
    Department of Dermatology, University Hospital Antwerp, Antwerp, Belgium
    J Invest Dermatol 125:665-72. 2005
    ..The psychometric properties of instruments designed to measure the impact of psoriasis should be tested in populations in which the instrument is to be applied...
  23. ncbi Comorbidities in dermatology
    Marlies Wakkee
    Department of Dermatology, Erasmus Medical Centre, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Dermatol Clin 27:137-47, vi. 2009
    ..This article discusses observational studies that assess comorbidities in psoriasis, atopic dermatitis, vitiligo, and nonmelanoma skin cancer, and the likelihood of the observed associations and their clinical consequences...
  24. ncbi Reactive oxygen species and melanoma: an explanation for gender differences in survival?
    Arjen Joosse
    Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Pigment Cell Melanoma Res 23:352-64. 2010
    ..Therefore, ROS may explain the observed differences between males and females in melanoma survival...
  25. ncbi Duplication of the great saphenous vein: a definition problem and implications for therapy
    Michael Kockaert
    Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands
    Dermatol Surg 38:77-82. 2012
    ....
  26. ncbi Minimally invasive techniques in the treatment of saphenous varicose veins
    Tamar Nijsten
    Department of Dermatology, Erasmus MC Rotterdam, Rotterdam, The Netherlands
    J Am Acad Dermatol 60:110-9. 2009
    ..The objective of this review is to inform clinicians about these 3 therapeutic options for truncal varicose veins and to describe and compare the procedures, indications, efficacy, and safety profile...
  27. ncbi How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review
    Phyllis I Spuls
    Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Invest Dermatol 130:933-43. 2010
    ..Overall, no best instrument was identified, and different situations may call for different measures...
  28. ncbi A comparative study on the efficacy of treatment with 585 nm pulsed dye laser and ultraviolet B-TL01 in plaque type psoriasis
    Jaap de Leeuw
    Department of Dermatology and Venereology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Dermatol Surg 35:80-91. 2009
    ..Narrow-band ultraviolet-B and pulsed dye laser (PDL) affect psoriasis but via different pathways...
  29. ncbi Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction
    Robert S Stern
    Beth Israel Deaconess Medical Center, Department of Dermatology, Harvard Medical School, Department of Dermatology, Boston, Massachusetts, USA
    J Investig Dermatol Symp Proc 9:136-9. 2004
    ..Many individuals with little psoriasis at the time of interview considered the disease to be a large problem in everyday life...
  30. ncbi Polymorphic light eruption may be associated with cigarette smoking and alcohol consumption
    Greet Mentens
    Department of Dermatology, University Hospital Antwerp, Edegem, Belgium
    Photodermatol Photoimmunol Photomed 22:87-92. 2006
    ..74 (95% CI=1.33, 16.86)]. CONCLUSION: Several lifestyle factors may be associated with PLE, but further studies are warranted to confirm these retrospective findings...
  31. ncbi Polidocanol concentration and time affect the properties of foam used for sclerotherapy
    Brend VAN Deurzen
    Faculty of Mechanical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
    Dermatol Surg 37:1448-55. 2011
    ..How foam is created for sclerotherapy varies and is not standardized. Moreover, the effect of several factors on the quality of the foam is not well studied...
  32. ncbi Clinical severity of psoriasis in last 20 years of PUVA study
    Tamar Nijsten
    Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands
    Arch Dermatol 143:1113-21. 2007
    ..To assess the severity of psoriasis over time...
  33. ncbi Endovenous therapies of lower extremity varicosities: a meta-analysis
    Renate van den Bos
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    J Vasc Surg 49:230-9. 2009
    ..These therapies have not yet been compared with surgical ligation and stripping in large randomized clinical trials...
  34. ncbi Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans
    Leonie C Jacobs
    Department of Dermatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Hum Genet 132:147-58. 2013
    ..The variants identified in this study may also contribute to the risk of skin cancer. Our findings are also important for predicting skin color in forensic investigations...
  35. ncbi High-ceiling diuretics are associated with an increased risk of basal cell carcinoma in a population-based follow-up study
    Rikje Ruiter
    Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands
    Eur J Cancer 46:2467-72. 2010
    ..Known risk factors for the development of BCC are age, sun exposure, and certain skin characteristics. Despite photosensitizing abilities of diuretic agents, little is known about a possible association with BCC...
  36. ncbi Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors
    Tamar Nijsten
    Department of Dermatology, University Hospital Antwerp, Antwerp, Belgium
    J Cutan Pathol 32:340-7. 2005
    ..Although PPARalpha, PPARbeta, and PPARgamma are expressed in multiple human, their expression has not been investigated in non-melanoma skin cancer...
  37. ncbi Population education in preventing skin cancer: from childhood to adulthood
    Ellen R M de Haas
    Department of Dermatology and bDepartment of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    J Drugs Dermatol 9:112-6. 2010
    ..In this review, various aspects of primary and secondary skin cancer prevention are discussed, including the results of some of the primary and secondary prevention initiatives...
  38. ncbi Laser fibre stabs the catheter: a serious complication of endovenous laser ablation
    R R van den Bos
    Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
    Phlebology 26:119-20. 2011
    ..Fortunately, there were no harmful sequelae in this case, but as device-related complications of EVLA are serious, reporting them is important...
  39. ncbi Endovenous therapies of varicose veins: indications, procedures, efficacy and safety
    A A M Biemans
    Department of Dermatology, Erasmus MC Rotterdam, Rotterdam, The Netherlands
    G Ital Dermatol Venereol 145:161-73. 2010
    ..The objective of this review is to inform clinicians about these three therapeutic options for saphenous varicose veins and to describe and compare the indications, procedures, efficacy and safety profile...
  40. ncbi The prevalence of psoriasis in African Americans: results from a population-based study
    Joel M Gelfand
    Department of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, PA 19104, USA
    J Am Acad Dermatol 52:23-6. 2005
    ..The prevalence of psoriasis in African Americans has been previously reported as rare. However, there have been no population-based studies to assess the prevalence and burden of psoriasis in African Americans...
  41. ncbi Impact of psoriasis on health-related quality of life decreases over time: an 11-year prospective study
    Jane Unaeze
    Harvard Medical School, Boston, Massachusetts, USA
    J Invest Dermatol 126:1480-9. 2006
    ..05). In this large cohort interviewed independent of treatments and psoriasis status, impact of psoriasis on HRQOL decreases over time. For chronic diseases, HRQOL is best measured over time and independently of seeking treatment...
  42. ncbi Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing
    Steven R Feldman
    Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
    J Am Acad Dermatol 52:140-1. 2005
  43. ncbi Members of the national psoriasis foundation: more extensive disease and better informed about treatment options
    Tamar Nijsten
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Arch Dermatol 141:19-26. 2005
    ..Our objective was to assess the extent to which NPF members differ from nonmember patients with psoriasis in their knowledge and use of therapies...
  44. ncbi Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey
    Tamar Nijsten
    Department of Dermatology at Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    J Am Acad Dermatol 52:434-44. 2005
    ..If we are to learn whether new treatments satisfy patients' needs, long term, prospective, comparative studies of heterogeneous patient populations that include patients' assessments are needed...
  45. ncbi Epidemiology of psoriatic arthritis in the population of the United States
    Joel M Gelfand
    Department of Dermatology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Am Acad Dermatol 53:573. 2005
    ..Estimates of the prevalence of psoriatic arthritis vary widely and are usually not determined by population-based studies...
  46. ncbi Dimensionality of the dermatology life quality index (DLQI): a commentary
    Tamar Nijsten
    Acta Derm Venereol 86:284-5; author reply 285-6. 2006
  47. ncbi Question the obvious
    Tamar Nijsten
    Arch Dermatol 143:1429-32. 2007